Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

531
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
531
Renal Corpuscle01:20

Renal Corpuscle

2.0K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.0K
Nephrons01:10

Nephrons

2.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.4K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Proteoglycans01:05

Proteoglycans

3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Liver Physiology01:30

Liver Physiology

518
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
518

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Challenges of Acute Kidney Injury in a Patient With High-Risk Multiple Myeloma: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Measuring effectiveness in immunoglobulin A nephropathy: what are we looking for?

Clinical kidney journal·2026
Same author

KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Malignancy-Associated Hypercalcemia and Kidney Disease: Facts, Controversies, and Management.

Kidney medicine·2026
Same author

Is Age Just a Number?: A Comparative Analysis of Glomerular Disease Across Ages from the Cure Glomerulonephropathy Network.

Kidney360·2025
Same author

The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes.

Current atherosclerosis reports·2025

Related Experiment Video

Updated: Jun 28, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K

Liver Disease-Associated Glomerulopathies.

Swetha R Kanduri1, Yonatan Peleg2, Shikha Wadhwani2

  • 1Department of Nephrology, Ochsner Health System, New Orleans, LA; Ochsner Clinical School, The University of Queensland, New Orleans, LA.

Advances in Kidney Disease and Health
|April 22, 2024
PubMed
Summary

Hepatitis B (HBV) and C (HCV) viruses can cause kidney disease, including IgA nephropathy. Antiviral therapy is the primary treatment for HBV- and HCV-related glomerulonephritis, improving outcomes.

Keywords:
CryoglobulinemiaGlomerular diseasesHepatitis BHepatitis CMembranous nephropathySecondary IgA nephropathy

More Related Videos

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.6K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.1K

Related Experiment Videos

Last Updated: Jun 28, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.6K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.1K

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause global health issues.
  • Extra-hepatic manifestations, such as glomerular disease, are recognized complications.
  • Liver disease-associated IgA nephropathy is a leading cause of secondary IgA nephropathy.

Purpose of the Study:

  • To review epidemiology, pathogenesis, clinical features, and treatment of HBV- and HCV-related glomerulonephritis.
  • To discuss IgA nephropathy in patients with liver disease.
  • To provide an updated perspective on these kidney diseases.

Main Methods:

  • Literature review of HBV- and HCV-related glomerulonephritis.
  • Analysis of IgA nephropathy associated with liver disease.
  • Synthesis of current knowledge on pathogenesis and treatment.

Main Results:

  • Membranous nephropathy is common in HBV-related glomerulonephritis; others include MPGN and podocytopathies.
  • HCV-related glomerulonephritis often presents as cryoglobulinemic glomerulonephritis.
  • Antiviral therapy, especially direct-acting antivirals, has improved HBV-GN and HCV-GN outcomes.

Conclusions:

  • Antiviral therapy is the cornerstone for treating HBV- and HCV-related glomerulonephritis.
  • Immunosuppression (e.g., anti-CD20) may be used for severe or aggressive cases.
  • Understanding these viral-associated kidney diseases is crucial for patient management.